G (Genpact) Research & Development: $0 Mil (TTM As of Mar. 2026)


G Genpact Ltd G
79 GF Score
Price $27.67
GF Value $46.58
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Genpact Research & Development?

Genpact G -3.01% 79 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates G with a GF Score™ of 79/100 and a GF Value™ of $46.58 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Genpact's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Genpact  (NYSE:G) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Genpact Research & Development Related Terms

Genpact Research & Development Historical Data

* Premium members only.

The historical data trend for Genpact's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genpact Research & Development Chart

Genpact Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Genpact Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
G
79GF Score
Genpact Ltd G
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genpact Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Genpact (G) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Genpact and its competitors.
Is Genpact's Research & Development too high?
Genpact's current Research & Development is $0 Mil. Overall, Genpact has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genpact's Research & Development compare to EPAM and PSN?
Genpact's Research & Development of $0 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Genpact and its competitors. Genpact's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genpact stock overvalued right now?
Based on GuruFocus' analysis, Genpact (G) is currently considered Significantly Undervalued. The stock's GF Value™ is $46.58, compared to a current price of $27.67 — trading 40.6% below its estimated fair value. The current Research & Development is $0 Mil. Genpact's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Genpact (G), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genpact (G) Overvalued in 2026?

Based on GuruFocus' analysis, Genpact stock appears to be undervalued. The current stock price of $27.67 is trading 40.6% below its estimated GF Value™ of $46.58. GuruFocus considers Genpact to be Significantly Undervalued.

Key valuation signals for G:

  • Research & Development: $0 Mil
  • GF Value™: $46.58 vs. price of $27.67 (40.6% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the G stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genpact Business Description

Other Exchanges 35G:Germany
Address 22 Victoria Street, Canon\'s Court, Hamilton, BMU, HM 12
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.
79GF Score

Get the complete analysis for G

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.67
Price
$46.58
GF Value